$AMN

The Medical Records Access Fairness Act of 2026 mandates standardized, interoperable electronic health record (EHR) access, creating a significant market for health IT solutions and data management. This bill directly benefits companies providing EHR systems, data integration, and secure cloud storage, while increasing compliance costs for healthcare providers.

The ASSIST Act of 2025, favorably reported by the Committee on Veterans' Affairs, expands healthcare access and support for veterans. This creates direct revenue opportunities for healthcare providers, diagnostic companies, and technology firms specializing in veteran services. Investors should anticipate increased contract awards in these areas.

This bill directly targets the availability of mifepristone, a key drug in reproductive healthcare. Its passage would eliminate a significant market for pharmaceutical companies and could increase demand for other healthcare services.

QTC Medical Services Inc., a subsidiary of Leidos Holdings Inc. ($LDOS), secured a $14.1M contract from the FBI for medical services. While not a major revenue driver for Leidos, this award highlights continued demand for specialized medical support within federal agencies, potentially benefiting diagnostic and staffing suppliers.

This $16.5 million contract for medical staffing services to NORTH EAST SOUTH WEST HEALTHCARE SOLUTIONS, LLC, a private entity, suggests a stable demand for healthcare personnel within federal agencies. Publicly traded healthcare staffing companies like AMN Healthcare Services ($AMN) and Robert Half International ($RHI) may see a slight positive sentiment due to sustained government spending in this sector, though direct revenue impact is negligible.

This $16.9M contract to NATIONWIDE HEALTHCARE SOLUTIONS, LLC for clinical support services is a moderate win for the private entity, but it highlights ongoing demand in the healthcare staffing and services sector, potentially benefiting publicly traded competitors.

The Pandemic and All-Hazards Preparedness Reauthorization Act of 2013 (S.242) ensures continued funding and strategic direction for public health emergency preparedness. This bill maintains existing support for pharmaceutical companies, medical device manufacturers, and healthcare service providers involved in national health security.

The BUST FENTANYL Act, S860, targets the fentanyl crisis through enhanced detection and interdiction. This bill increases demand for drug screening technologies, laboratory services, and pharmaceutical countermeasures, directly benefiting companies in these sectors.

The Veterans' Access to Care through Choice, Accountability, and Transparency Act of 2014 significantly increased funding for private sector healthcare services for veterans, driving demand for non-VA healthcare providers. This legislation directly expanded the addressable market for private hospitals, clinics, and medical staffing agencies.

The Medical Supply Chain Security Act (HR6049) aims to bolster domestic medical supply production and reduce reliance on foreign sources. This will directly benefit U.S.-based medical device and pharmaceutical manufacturers, increasing their market share and contract opportunities. Healthcare providers will also see improved supply stability.

The 'Sustainable Cardiopulmonary Rehabilitation Services in the Home Act' expands Medicare coverage for home-based cardiopulmonary rehabilitation, directly increasing revenue opportunities for healthcare providers and home health agencies. This bill shifts a portion of rehabilitation services from facility-based to home-based settings, benefiting companies with robust home health infrastructure.

The Reducing Hereditary Cancer Act, HR4752, directs significant resources towards genetic testing and counseling for hereditary cancer. This creates a direct revenue stream for genetic testing companies and healthcare providers specializing in cancer diagnostics and prevention.

The Rural Hospital Flexibility Act of 2025 (HR6804) provides financial and operational support to rural hospitals, directly benefiting healthcare providers operating in underserved areas. This bill increases the viability of smaller healthcare systems and related service providers. Companies with significant rural hospital exposure will see increased revenue stability and growth opportunities.